Thermo Fisher Scientific (TMO) Revenue (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Revenue for 18 consecutive years, with $12.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 10.49% year-over-year to $12.0 billion; the trailing twelve-month figure through Jun 2026 stood at $46.3 billion (up 7.23% YoY), and the FY2025 full-year result was $44.6 billion, up 3.91% from the prior year.
• Revenue grew to $12.0 billion in Q2 2026 per TMO's latest filing, from $11.0 billion in the prior quarter.
• Across five years, Revenue topped out at $12.2 billion in Q4 2025 and bottomed at $10.3 billion in Q1 2024.
• Historically, Revenue has averaged $11.0 billion across 5 years, with a median of $10.9 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue rose 19.3% in 2022, then retreated 9.38% in 2023.
• Over 5 years, Revenue stood at $11.5 billion in 2022, then dropped by 4.93% to $10.9 billion in 2023, then increased by 4.68% to $11.4 billion in 2024, then gained by 7.2% to $12.2 billion in 2025, then slipped by 1.81% to $12.0 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $12.0 billion, $11.0 billion, and $12.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.